ENvue Medical, Inc. (FEED)Healthcare | Medical Devices | Tyler, United States | NasdaqCM
0.34 USD
-0.02
(-6.360%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 0.36 +0.02 (4.499%) ⇧ (Aug. 28, 2026, 7:58 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 4:54 a.m. EDT
The immediate outlook is severely bearish, driven by a catastrophic multi-year price collapse where the asset has lost 99.95% of its value over the last nine years. The most recent annual performance was a staggering 91.48% decline, indicating a deep structural deterioration rather than a temporary correction. Fundamentals confirm this distress: the company is burning cash with negative operating margins of nearly 23%, negative free cash flow, and a trailing EPS of -$25.22. The balance sheet is fragile, with debt significantly exceeding equity and a current ratio well below 1.0, suggesting liquidity risks. While the stock recently bounced off its 52-week low, this appears to be a dead-cat bounce in a failing business rather than a recovery signal. There is no dividend to provide income, and the lack of analyst coverage combined with massive insider selling further erodes confidence. The statistical forecast models also lean negative, though their low reliability cannot override the glaring fundamental rot. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.198098 |
| AutoARIMA | 0.198128 |
| AutoTheta | 0.199674 |
| MSTL | 0.212840 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 42% |
| H-stat | 0.79 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.319 |
| Excess Kurtosis | -0.46 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 4.259 |
| Revenue per Share | 0.675 |
| Market Cap | 3,818,650 |
| Beta | 1.35 |
| Previous Name | NanoVibronix, Inc. |
| Website | https://envuemed.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.93210334 |
| Address1 | 969 Pruitt Ave |
| All Time High | 18,700.0 |
| All Time Low | 0.29 |
| Ask | 0.4329 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 248,210 |
| Average Daily Volume3 Month | 1,222,777 |
| Average Volume | 1,222,777 |
| Average Volume10Days | 248,210 |
| Beta | 1.347 |
| Bid | 0.2369 |
| Bid Size | 2 |
| Book Value | 8.651 |
| City | Tyler |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.3445 |
| Current Ratio | 0.66 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 0.35 |
| Day Low | 0.3283 |
| Debt To Equity | 4.259 |
| Display Name | ENvue Medical |
| Ebitda | -14,141,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.304 |
| Enterprise To Revenue | 2.235 |
| Enterprise Value | 4,304,030 |
| Eps Trailing Twelve Months | -25.22 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.45036 |
| Fifty Day Average Change | -0.105859995 |
| Fifty Day Average Change Percent | -0.23505639 |
| Fifty Two Week Change Percent | -93.210335 |
| Fifty Two Week High | 17.4 |
| Fifty Two Week High Change | -17.0555 |
| Fifty Two Week High Change Percent | -0.9802012 |
| Fifty Two Week Low | 0.29 |
| Fifty Two Week Low Change | 0.054500014 |
| Fifty Two Week Low Change Percent | 0.18793109 |
| Fifty Two Week Range | 0.29 - 17.4 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,432,819,800,000 |
| Float Shares | 11,084,615 |
| Free Cashflow | -5,824,500 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 12 |
| Fullday Change | -0.0234 |
| Fullday Change Percent | -6.36043 |
| Fullday Price | 0.36 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | -0.26064 |
| Gross Profits | -502,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.16409001 |
| Held Percent Institutions | 0.02661 |
| Implied Shares Outstanding | 11,084,615 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,754,956,800 |
| Last Split Factor | 1:10 |
| Long Business Summary | ENvue Medical, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance. Its product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers UroShield Ultra, which is designed to prevent bacterial colonization and biofilm formation in urinary catheters; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures. In addition, it provides PainShield MD, a single patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; PainShield Plus, a dual patch-based therapeutic ultrasound technology; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Europe, Australia, Israel, New Zealand, and internationally. ENvue Medical, Inc. was formerly known as NanoVibronix, Inc. and changed its name to ENvue Medical, Inc. in December 2025. The company was incorporated in 2003 and is based in Tyler, Texas. |
| Long Name | ENvue Medical, Inc. |
| Market | us_market |
| Market Cap | 3,818,650 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_27619235 |
| Most Recent Quarter | 1,782,777,600 |
| Name Change Date | 2,026-08-28 |
| Net Income To Common | -49,188,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 4,081,355 |
| Open | 0.3385 |
| Operating Cashflow | -11,649,000 |
| Operating Margins | -22.90377 |
| Payout Ratio | 0.0 |
| Phone | 914-233-3004 |
| Post Market Change | 0.015500009 |
| Post Market Change Percent | 4.4992766 |
| Post Market Price | 0.36 |
| Post Market Time | 1,787,961,521 |
| Prev Name | NanoVibronix, Inc. |
| Previous Close | 0.3679 |
| Price Hint | 4 |
| Price To Book | 0.039821986 |
| Price To Sales Trailing12 Months | 1.9826844 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.217 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.0234 |
| Regular Market Change Percent | -6.36043 |
| Regular Market Day High | 0.35 |
| Regular Market Day Low | 0.3283 |
| Regular Market Day Range | 0.3283 - 0.35 |
| Regular Market Open | 0.3385 |
| Regular Market Previous Close | 0.3679 |
| Regular Market Price | 0.3445 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 464,956 |
| Return On Assets | -0.20987 |
| Return On Equity | -0.59137 |
| Revenue Growth | -0.516 |
| Revenue Per Share | 0.675 |
| Sand P52 Week Change | 0.1966995 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 11,084,615 |
| Shares Percent Shares Out | 0.037 |
| Shares Short | 344,075 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 161,665 |
| Short Name | ENvue Medical, Inc. |
| Short Percent Of Float | 0.0374 |
| Short Ratio | 0.25 |
| Source Interval | 15 |
| State | TX |
| Symbol | FEED |
| Total Cash | 1,084,000 |
| Total Cash Per Share | 0.098 |
| Total Debt | 1,310,000 |
| Total Revenue | 1,926,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -25.22 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.78509 |
| Two Hundred Day Average Change | -1.4405899 |
| Two Hundred Day Average Change Percent | -0.8070125 |
| Type Disp | Equity |
| Volume | 464,956 |
| Website | https://envuemed.com |
| Zip | 77,569 |